This study compares the persistence of measles IgG antibody in 239 children vaccinated at
6–8 months of age with 76 children vaccinated after 8 months of age. Among the children …

Background: Despite a global decline in mortality and morbidity from measles in the last
decade, outbreaks continue to occur in some parts of the world including Nigeria. Objective …

We investigated optimal age of measles immunization in infants aged 3–11 months in rural
villages of Ghana, and determined seroconversion rate in the same infant population …

Summary objective To measure the protective effect of measles vaccine administered before
9 months of age and compare overall mortality of children vaccinated at 6–8 months and at 9 …

Background. Few data exist on the persistence of measles antibodies after vaccination of
West African infants. Therefore we examined measles antibody titers 5 to 7 years after …

A minimum age for measles vaccine administration to coloured children Page 1 8 ~overnber
1975 SA MEDICAL JOURNAL 1951 A Minimum Age for Measles Vaccine Administration to …

Objective To assess the efficacy of the current measles immunization schedule in Papua
New Guinea, which is to give the first dose at 6 months of age and the second at 9 months …

The antibody response to attenuated live virus measles vaccine (Rimevax) was assessed in
280 children between the ages of 6 and 12 months. Blood samples were taken before and …

High morbidity and mortality from measles among infants under 9 months of age is an
obstacle to measles control in many developing countries. In this paper, we review 30 …

A concurrent prospective study was conducted in Rwanda to compare the Immunogenicity
and safety of live, attenuated measles vaccine in ill and well children. Five hundred and …